The current results that LMP1 inhibits the expression of apoptosis-related genes (PDCD4 and Fas-L) and thereby contributes to cisplatin resistance suggest that assessing PDCD4 and Fas-L level may help predict cisplatin responses in NPC. This evidence concerns the gene FASLG and nasopharyngeal carcinoma.